A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 Followed by PNEUMOVAX™23 in Healthy Adults 50 Years of Age or Older (V114-016/PNEU-PATH)
Condition(s):Pneumococcal InfectionsLast Updated:November 2, 2021Completed
Hide Studies Not Open or Pending
Condition(s):Pneumococcal InfectionsLast Updated:November 2, 2021Completed
Condition(s):Pneumococcal Vaccine Adverse ReactionLast Updated:September 16, 2020Unknown status
Condition(s):Healthy ControlsLast Updated:September 28, 2015Completed
Condition(s):Pneumococcal InfectionsLast Updated:December 13, 2018Completed
Condition(s):Pneumococcal Pneumonia; InfluenzaLast Updated:January 31, 2019Completed
Condition(s):Pneumococcal DiseaseLast Updated:November 28, 2023Completed
Condition(s):Pneumococcal InfectionsLast Updated:November 2, 2021Completed
Condition(s):Rheumatoid Arthritis; SpondylarthropathyLast Updated:December 12, 2018Completed
Condition(s):Pneumococcal InfectionLast Updated:March 14, 2017Completed
Condition(s):Pneumococcal InfectionLast Updated:October 30, 2018Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.